Showing 6311-6320 of 20929 results for "".
- Using AI for Enhanced Post-Operative Pain Management After Knee Replacementhttps://reachmd.com/news/using-ai-for-enhanced-post-operative-pain-management-after-knee-replacement/2474465/Artificial intelligence (AI) is reshaping post-operative pain management, particularly following knee replacement surgeries. By analyzing extensive patient data, AI systems are enhancing the precision of pain assessments, leading to more personalized and effective treatment stra
- How Smartphone Apps Are Transforming Asthma Managementhttps://reachmd.com/news/digital-health-tools-asthma-symptom-tracking-and-patient-empowerment/2474453/The rapid rise of digital health tools is reshaping chronic disease care, and asthma is no exception. At the heart of this shift are smartphone apps, which are revolutionizing how patients monitor symptoms, identify triggers, and adhere to treatment. What was once
- Advancing HIV Vaccine Development: The Emerging Role of Lipid-Targeted Antibodieshttps://reachmd.com/news/advancing-hiv-vaccine-development-the-emerging-role-of-lipid-targeted-antibodies/2474462/Recent research unveils how lipid-targeted antibodies are reshaping HIV vaccine strategies, offering new avenues for effective immunization. Despite intensive efforts, HIV vaccine research has been hampered by the virus’s rapid mutatio
- Harnessing AI in Healthcare: Reducing Documentation Burden and Enhancing Risk Predictionhttps://reachmd.com/news/harnessing-ai-in-healthcare-reducing-documentation-burden-and-enhancing-risk-prediction/2474461/Clinicians are increasingly turning to artificial intelligence (AI) to alleviate the administrative burdens of clinical documentation and to enhance predictive capabilities in patient care. Innovations such as ambient AI technologies are stre
- The Hidden Risk of Gluten-Free Diets for Children: Arsenic Exposure in Pediatric Celiac Diseasehttps://reachmd.com/news/the-hidden-risk-of-gluten-free-diets-for-children-arsenic-exposure-in-pediatric-celiac-disease/2474463/Recent studies have revealed that children newly diagnosed with celiac disease experience a significant increase in urinary arsenic levels after transitioning to a gluten-free diet. This finding underscores the need for healthcare providers t
- Maternal Syphilis Exposure and Early Childhood Hospitalizationhttps://reachmd.com/news/maternal-syphilis-exposure-and-early-childhood-hospitalization/2474415/A growing body of evidence is casting renewed urgency on the dangers of maternal syphilis during pregnancy. New research reveals that infants exposed to syphilis in utero face an alarming 11-fold increase in the risk of hospitalization within their first month of l
- Vaccine Timing and Menstrual Health: Understanding Minor Cycle Shiftshttps://reachmd.com/news/vaccine-timing-and-menstrual-health-understanding-minor-cycle-shifts/2474432/Recent insights from Oregon Health & Science University suggest that administering vaccines dur
- Global Pandemic Preparedness: Evaluating Gaps and Lessons from COVID-19https://reachmd.com/news/global-pandemic-preparedness-evaluating-gaps-and-lessons-from-covid-19/2474434/The COVID-19 pandemic laid bare significant deficiencies in global readiness. Despite the hard-earned lessons of recent years, many of these vulnerabilities remain unaddressed. A growing body of evidence underscores the failure to integrate these lessons into actio
- Digital Cognitive Assessments: Evaluating Feasibility for Dementia Screening in Primary Carehttps://reachmd.com/news/digital-cognitive-assessments-evaluating-feasibility-for-dementia-screening-in-primary-care/2474431/Digital cognitive assessments are gaining prominence as a compelling method for routine dementia screening within primary care settings. Recent evaluations confirm their effective integration into standard patient visits, providing an unsurpassed approach for the e
- The Role of PRMT5 in Chemotherapy Resistance in Ovarian Cancerhttps://reachmd.com/news/the-role-of-prmt5-in-chemotherapy-resistance-in-ovarian-cancer/2474426/Recent investigations highlight the crucial role of the enzyme PRMT5 in mediating chemotherapy resistance in advanced ovarian cancer, signaling a shift towards more personalized therapeutic strategies. This discovery, pertinent to both Oncology